TORONTO, March 21 /PRNewswire-FirstCall/ -- MedCap Corp (Pinksheets: MPCPF) is pleased to announce that the AccuScan Drugs of Abuse have received Health Canada manufacturers certificate to cover the export of medical devices. This certification of the test kits will be very helpful in its marketing program, particularly in China.
Preliminary test results in China have been excellent. The certifications combined with the test results should result in significant orders within the next 60 days. The certification verifies that the kits are produced using GMP standards.
The Company is continuing to negotiate with distributors for the AccuScan in different parts of the world based on market studies which show the areas of greatest potential.
MedCap trades in the United States on the Pinksheets under the symbol "MPCPF". For further information, please contact Cazgeld Capital Corporation at (416) 363 0070 or at http://www.medccorp.com/ .
NOTE: This release may contain forward-looking statements that involve uncertainties and risks. Actual results may differ materially from any results predicted. MedCap undertakes no obligation to release publicly any revisions to any forward-looking statements to reflect events of circumstances after the date hereof.
CONTACT: Cazgeld Capital Corporation, +1-416-363-0070